ppt - PowerPoint Presentation
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy Report of the TTA and QSS Subcommittees of the American.
Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New Onset Epilepsy Report of the TTA and QSS Subcommittees of the American Academy.
Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy
Practice Parameter: Immunotherapy for Guillain-Barré syndrome A report of the Quality Standards Subcommittee (QSS) of the American Academy of Neurology.
